60/100B82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
If you had invested in GE HealthCare Technologies ago, it would be worth $1,165 today, against $1,750 in SPY and $1,807 in QQQ.
Arincen ScoreWhat is the Arincen Score? The Arincen Score grades a company out of 100 from 30 checks on its own reported figures, five checks in each of six parts.Beta
60/100
Six parts of the company, five checks each, from its own reported figures. A part scores the checks it passes out of 10; the score is their average out of 100.
Profitability8
Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.
Cash6
Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.
Valuation6
Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.
Growth6
Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.
Financial strength2
Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.
Shareholders8
Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.
Figures to FY2025; the price as of today.
GE HealthCare Technologies key facts
- StyleWhat does a stock's style mean? The style label sorts a stock as growth, value, dividend, blend or speculative, with a 1 to 10 meter showing how strongly it fits.
- Value stock · 5.8/10Growth 3.8 · Value 5.8 · Dividend 1.0
- Day range
- 81.755 – 83.240
- 52-week range
- 58.750 – 89.770
- Market capitalizationWhat is market capitalization? Market cap is what the stock market values a whole company at: its share price times the number of its shares outstanding.
- 37.25B USD
- P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 21.34
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 2.02
- EPSWhat is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
- 3.86
- Div YieldWhat is dividend yield? Dividend yield is a year of dividends as a percentage of the share price: the income a shareholder receives for each dollar invested at today's price.
- 0.19%
- EPS growth forecast (FY2026)
- +9.5%
- Volume
- 0
- BetaWhat is beta in stocks? Beta measures how much a stock tends to move when the whole market moves: 1 moves with it, under 1 is calmer, over 1 swings more.
- 0.77
- ESG scoreWhat is an ESG score? An ESG score rates how a company handles the environment, its people and its governance, out of 100. Higher is better.
- 68.5/100Environment 64 · Social 72 · Governance 69
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Peter J. Arduini
- Employees
- 54K
- Website
- gehealthcare.com
- IPO date
- 15 Dec 2022
GE HealthCare Technologies earningsWhat is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
Next earnings · Q4 FY2026
EPS estimate
1.55 USD
Revenue estimate
5.92B USD
Last quarter · Q3 FY2026
EPS1.34Beat +11.7%Revenue5.51BBeat +3.0%
Revenue
ReportedEstimate
EPS
ReportedEstimate
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY2027 | 1.42 | — | — | +6.22% | 5.75B | — | — | +4.25% | |
| Q2 FY2027 | 1.26 | — | — | +11.60% | 5.54B | — | — | +4.65% | |
| Q1 FY2027 | 1.11 | — | — | +12.43% | 5.36B | — | — | +4.52% | |
| Q4 FY2026 | 1.55 | — | — | +7.64% | 5.92B | — | — | +3.97% | |
| Q3 FY2026 | 1.20 | 1.34 | +11.67% | +25.23% | 5.35B | 5.51B | +3.02% | +7.19% | |
| Q2 FY2026 | 1.04 | 1.13 | +8.65% | +6.60% | 5.26B | 5.30B | +0.59% | +5.77% | |
| Q1 FY2026 | 1.04 | 0.99 | -4.81% | -1.98% | 5.04B | 5.13B | +1.76% | +7.41% | |
| Q4 FY2025 | 1.40 | 1.44 | +2.86% | -0.69% | 5.61B | 5.70B | +1.51% | +7.13% | |
| Q3 FY2025 | 1.05 | 1.07 | +1.90% | -6.14% | 5.09B | 5.14B | +1.10% | +5.76% | |
| Q2 FY2025 | 0.92 | 1.06 | +15.47% | +6.00% | 4.97B | 5.01B | +0.66% | +3.45% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 6.13 | — | — | +11.02% | 24.09B | — | — | +5.02% |
| FY2027 | 5.52 | — | — | +9.99% | 22.94B | — | — | +4.89% |
| FY2026 | 5.02 | — | — | +9.55% | 21.87B | — | — | +6.03% |
| FY2025 | 4.55 | 4.58 | +0.68% | +2.00% | 20.53B | 20.62B | +0.44% | +4.84% |
| FY2024 | 4.30 | 4.49 | +4.52% | +13.96% | 19.68B | 19.67B | -0.03% | +0.61% |
| FY2023 | 3.82 | 3.94 | +3.25% | — | 19.42B | 19.55B | +0.66% | — |
GE HealthCare Technologies analyst forecastWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
12-month price target
81.14 USD
-1.51%
Analysts' 1-year price targets range from 67.00 to 95.00, with an average of 81.14.
Past year
1-year forecast
Strong sellStrong buy
Buy
16 ratings
| Buy | 10 | |
| Hold | 6 | |
| Sell | 0 |
12-month price target
| Highest target | 95.00 |
| Average target | 81.14 |
| Lowest target | 67.00 |
| Current price | 82.39 |
GE HealthCare Technologies valuationWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 21.34
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 16.42
- Price to sales (TTM)What is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
- 1.81
- Price to bookWhat is the P/B ratio? The price-to-book ratio compares a company's market value with its book value, the shareholders' equity on its balance sheet.
- 3.21
- EV / EBITDA (TTM)What is EV/EBITDA? EV/EBITDA compares a company's whole value, debt included and cash taken off, with a year of its earnings before interest, tax and depreciation.
- 13.97
Capital structureWhat is enterprise value? Enterprise value is what the whole business costs: the market value of its shares plus its debt minus its cash. It is the price behind EV/EBITDA.
Market capitalization
37.25B USD
+
Total debt
10.41B USD
−
Cash and short-term investments
2.85B USD
=
Enterprise value
44.80B USD
Valuation over time
P/EForward P/EForward P/E · EstimateEstimate
GE HealthCare Technologies against its own historyWhat does "against its own history" show? The company's latest margins, return on equity, growth, debt and P/E against its own last 5 years: the low, the median and the high, and whether this year is better or worse than usual.
Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.
Its peers: DexCom, Edwards Lifesciences, Boston Scientific, Zimmer Biomet Holdings, Glaukos, and Penumbra, the US Medical - Devices companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.
- P/E (today)Above its median21.313.130.8
- Gross marginBelow its median40.0%39.1%41.7%Against its peers: 7 of 7Peers' median 68.1%
- Operating marginAt its median13.4%12.5%15.9%Against its peers: 6 of 7Peers' median 18.1%
- Net marginBelow its median10.1%8.0%12.8%Against its peers: 5 of 7Peers' median 13.5%
- Return on equityBelow its median20.1%13.5%23.6%Against its peers: 2 of 7Peers' median 11.1%
- Free cash flow marginLowest in 5 years7.3%7.3%9.8%Against its peers: 6 of 7Peers' median 18.1%
- Revenue growthAbove its median4.8%0.6%6.6%Against its peers: 7 of 7Peers' median 16.5%
- EPS growthAt its median4.8%-28.4%43.7%Against its peers: 4 of 6Peers' median 47.2%
- Debt to EBITDAAt its median2.64×0.12×2.81×Against its peers: 5 of 6Peers' median 1.02×
- Current ratioHighest in 5 years1.180.971.18Against its peers: 7 of 7Peers' median 2.85
Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.
GE HealthCare Technologies growth and profitabilityWhat are gross, operating and net profit margins? A profit margin is the share of revenue kept as profit: gross margin after the cost of sales, operating margin after running costs, net margin after all costs.
- Revenue (TTM)What does TTM (trailing twelve months) mean? TTM (trailing twelve months) is a figure over the latest twelve months of reports: usually the last four quarters added together.
- 20.61B USD
- Net income (TTM)What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
- 1.76B USD
- Gross marginWhat are gross, operating and net profit margins? A profit margin is the share of revenue kept as profit: gross margin after the cost of sales, operating margin after running costs, net margin after all costs.
- 43.27%
- Operating margin
- 13.21%
- Net margin
- 8.54%
Revenue / Net income
Revenue Net income Net margin
GE HealthCare Technologies revenue breakdown
By product
FY2025
60.7%Imaging20.3%PCS19.0%PDx
| Segment | Revenue | Share of revenue | Change on the year |
|---|---|---|---|
| Imaging | 9.25B | 60.7% | +4.4% |
| PCS | 3.09B | 20.3% | -1.2% |
| PDx | 2.90B | 19.0% | +15.6% |
By region
FY2025
45.7%Other Countries44.4%United States9.8%China
| Region | Revenue | Share of revenue | Change on the year |
|---|---|---|---|
| Other Countries | 9.43B | 45.7% | +5.7% |
| United States | 9.17B | 44.4% | +6.4% |
| China | 2.03B | 9.8% | -4.9% |
How GE HealthCare Technologies makes its moneyWhat is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
Revenue20.63B 100.0%
Cost of revenue12.38B 60.0%
Gross profit8.25B 40.0%
Research and development1.26B 6.1%
Selling and administration4.23B 20.5%
Operating income2.76B 13.4%
Tax614.00M 3.0%
Other expense64.00M 0.3%
Net income2.08B 10.1%
FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.
FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.
GE HealthCare Technologies dividendsWhat is dividend yield? Dividend yield is a year of dividends as a percentage of the share price: the income a shareholder receives for each dollar invested at today's price.
- Annual dividend
- 0.16 USD
- Dividend yield (indicated)What is dividend yield? Dividend yield is a year of dividends as a percentage of the share price: the income a shareholder receives for each dollar invested at today's price.
- 0.19%
- Payout ratioWhat is the payout ratio? The payout ratio is the share of a company's earnings paid out as dividends: dividends per share divided by earnings per share (EPS).
- 3.76%
- Years of dividend growthWhat are years of dividend growth? The years in a row a company has raised its dividend per share. 25 years make an S&P 500 company a Dividend Aristocrat; 50 make a Dividend King.
- 2
- Frequency
- Quarterly
- Next payment
- 0.04 USD
- Last ex-dividend dateWhat is the ex-dividend date? The ex-dividend date is the first day a stock trades without its next dividend: buy before it to receive the payment; buy on or after it and the seller gets it.
- 23 Oct 2026
- Next payment date
- 13 Nov 2026
Dividends per share
GE HealthCare Technologies financial health
- Cash and short-term investments
- 2.85B USD
- Total debt
- 10.41B USD
- Net cash
- -7.55B USD
- Free cash flow (TTM)What is free cash flow (FCF)? Free cash flow is the cash a company's operations bring in minus what it spends on long-term assets (capex): cash left for debt, dividends and buybacks.
- 1.21B USD
- Current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
- 1.30
- Debt to equityWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
- 0.90
- Piotroski scoreWhat is the Piotroski F-Score? The Piotroski F-Score rates a company's financial strength from 0 to 9: one point for each of nine tests of profit, debt and efficiency it passes.
- 6 / 9
- Altman Z-scoreWhat is the Altman Z-Score? The Altman Z-Score rolls five financial ratios into one number that signals a company's risk of bankruptcy: over 3 is safe, under 1.8 is distress.
- 1.94
Cash, debt and free cash flow
Cash and short-term investments Total debt Free cash flow
GE HealthCare Technologies ownershipWhat is institutional ownership? Institutional ownership is the share of a company's stock held by funds, banks and other investment managers, as they report it each quarter on Form 13F.
- InstitutionsWhat is institutional ownership? Institutional ownership is the share of a company's stock held by funds, banks and other investment managers, as they report it each quarter on Form 13F.
- 87.73%
- Institutional holders
- 1,271 (-48)
- Free floatWhat is free float? Free float is the part of a company's shares that anyone can buy and sell: all its shares minus those held by insiders, founders and owners of over 5%.
- 99.67%
Who owns the shares
Institutions 87.7% Others 12.3%
As of 30 Jun 2026
Shares free to trade
Free float 450.65M shares ·99.7% Closely held 1.49M shares ·0.3%
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
Insider trading
| Quarter | Purchases | Sales | Shares acquired | Shares disposed of |
|---|---|---|---|---|
| Q3 2026 | 0 | 0 | 106.97K | 33.62K |
| Q2 2026 | 8 | 0 | 154.34K | 5.54K |
| Q1 2026 | 0 | 0 | 613.76K | 74.61K |
| Q3 2025 | 0 | 0 | 15.56K | 35.60K |
Shares outstanding
Basic shares Diluted shares Change in diluted shares
Source: Financial Modeling Prep
Title: GE HealthCare Technologies
Sector: Healthcare
Industry: Medical - Devices
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).